Ciprofloxacin

Product NDC
76420-928
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ciprofolxacin
Dosage form
TABLET
Route
ORAL
Labeler
Asclemed USA, Inc.
Application
ANDA208921
Marketing category
ANDA
Substance
CIPROFLOXACIN HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
76420-928-9090 TABLET in 1 BOTTLE (76420-928-90) 20250328NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
c4eecdf8-9e50-4e44-aca1-b9c19317d52aThese highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablets, for oral use Initial U.S. Approval: 1987Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM2025-03-28HUMAN PRESCRIPTION DRUG LABEL1